PTGX
#1009
Protagonist Therapeutics, Inc. - Common Stock
129.8 9 USD
-0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.16%
Monthly Change
+18.08%
6 month change
+53.53%
Year Change
+72.89%
Previous Close
131.4 2
Open
129.8 9
Low
129.8 9
High
129.8 9
Volume
145
Financials
- Market Capitalization 8.35 B
- Employee 131
- Founded 2006
- CEO N/A
- Website www.protagonist-inc.com
- Headquarter Delaware, United States
- FIGI BBG002B63KM7
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-42.6
Price to sales ratio
120.66
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 987 |  PRAX Praxis Precision Medicines, Inc. - Common Stock | 314.56 USD | -3.21% | -0.17% | +16.12% | +482.63% | 8.77 B USD | ||
| 1003 |  TGTX TG Therapeutics, Inc. - Common Stock | 55.01 USD | -3.69% | -1.36% | +12.27% | +41.09% | 8.42 B USD | ||
| 1012 |  APGE Apogee Therapeutics, Inc. - Common Stock | 133.82 USD | +0.13% | +0.25% | +49.25% | +149.71% | 8.28 B USD | ||
| 1016 |  PCVX Vaxcyte, Inc. - Common Stock | 57.03 USD | -2.03% | -1.30% | +19.53% | +34.82% | 8.23 B USD |
Frequently asked questions about Protagonist Therapeutics, Inc. - Common Stock
What is the Protagonist Therapeutics, Inc. - Common Stock stock price today?
The current price of Protagonist Therapeutics, Inc. - Common Stock (PTGX) is 129.89. Over the past 24 hours, the stock has changed by -1.16%. Follow the PTGX chart for real-time price dynamics.
What is the stock ticker of Protagonist Therapeutics, Inc. - Common Stock?
Protagonist Therapeutics, Inc. - Common Stock trades under the ticker PTGX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Protagonist Therapeutics, Inc. - Common Stock stock going up?
PTGX has changed by -2.04% over the last week, +18.08% over the last month, and +72.89% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Protagonist Therapeutics, Inc. - Common Stock net income for the last quarter?
Protagonist Therapeutics, Inc. - Common Stock reported net income of 3.78 M for the last quarter. The previous quarter showed -44.38 M, which means net income changed by +108.52%.
How many employees does Protagonist Therapeutics, Inc. - Common Stock have?
As of the latest available data, Protagonist Therapeutics, Inc. - Common Stock has 131 employees. Workforce size can provide additional context about the company's scale and operations.
What is Protagonist Therapeutics, Inc. - Common Stock EBITDA?
Protagonist Therapeutics, Inc. - Common Stock EBITDA is -3.24 M, and its EBITDA margin is -5.75%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Protagonist Therapeutics, Inc. - Common Stock stock?
You can buy Protagonist Therapeutics, Inc. - Common Stock (PTGX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Protagonist Therapeutics, Inc. - Common Stock stock?
Investing in Protagonist Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PTGX chart and related analysis on metatrader.com as part of your research.